N-[3-[[4-(1-cyclopentylethenyl)piperazin-1-yl]methyl]-5-fluoro-2-methylphenyl]-4-fluoro-2-methylbenzamide
C27H33F2N3O — CID 126712054
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[[4-(1-cyclopentylethenyl)piperazin-1-yl]methyl]-5-fluoro-2-methylphenyl]-4-fluoro-2-methylbenzamide
N-[3-[[4-(1-cyclopentylethenyl)piperazin-1-yl]methyl]-5-fluoro-2-methylphenyl]-4-fluoro-2-methylbenzamide (PubChem CID 126712054) has the molecular formula C27H33F2N3O and a molecular weight of 453.58 g/mol. Its IUPAC name is N-[3-[[4-(1-cyclopentylethenyl)piperazin-1-yl]methyl]-5-fluoro-2-methylphenyl]-4-fluoro-2-methylbenzamide.
Molecular Properties
| Compound Name | N-[3-[[4-(1-cyclopentylethenyl)piperazin-1-yl]methyl]-5-fluoro-2-methylphenyl]-4-fluoro-2-methylbenzamide |
|---|---|
| PubChem CID | 126712054 |
| Molecular Formula | C27H33F2N3O |
| Molecular Weight | 453.58 g/mol |
| Exact Mass | 453.26 |
| IUPAC Name | N-[3-[[4-(1-cyclopentylethenyl)piperazin-1-yl]methyl]-5-fluoro-2-methylphenyl]-4-fluoro-2-methylbenzamide |
| SMILES | C=C(C1CCCC1)N1CCN(Cc2cc(F)cc(NC(=O)c3ccc(F)cc3C)c2C)CC1 |
| InChI | InChI=1S/C27H33F2N3O/c1-18-14-23(28)8-9-25(18)27(33)30-26-16-24(29)15-22(19(26)2)17-31-10-12-32(13-11-31)20(3)21-6-4-5-7-21/h8-9,14-16,21H,3-7,10-13,17H2,1-2H3,(H,30,33) |
| InChIKey | RJGFXVRRPAEWTC-UHFFFAOYSA-N |
| XLogP | 5.66 |
| TPSA | 35.58 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.58 |
| LogP ≤ 5 | 5.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126712054 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.